Clinical trial
Assessment of Pregabalin Efficacy for the Treatment and Prevention of At-level Non-evoked and Evoked Spinal Cord Injury Neuropathic Pain
NCT01479556 is registered in ClinicalTrials.gov with Julian Taylor Green as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Pregabalin Efficacy for the Treatment and Prevention of At-level Non-evoked and Evoked Spinal Cord Injury Neuropathic Pain
- Lead sponsor
- Julian Taylor Green
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2011
- Completion date
- October 31, 2014
- Enrollment
- 82 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuropathic pain, spinal cord injuries